We are live on ! Find out more
CF

CNA Financial Portfolio holdings

AUM $235M
1-Year Est. Return 3.39%
This Fund
S&P 500
This Quarter Est. Return
-14.16%
1 Year Est. Return
+3.39%
3 Year Est. Return
+50.54%
5 Year Est. Return
+66.93%
10 Year Est. Return
+254.04%
AUM
$286M
AUM Growth
-$36.4M
Cap. Flow
+$14.1M
Cap. Flow %
4.94%
Top 10 Hldgs %
40.07%
Holding
198
New
11
Increased
56
Reduced
46
Closed
25

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$7.1M
2
MS icon
Morgan Stanley
MS
+$6.12M
3
TDY icon
Teledyne Technologies
TDY
+$5.2M
4
CVS icon
CVS Health
CVS
+$5.06M
5
KEYS icon
Keysight
KEYS
+$4.74M

Sector Composition

Rank Sector Weight
1 Healthcare 21.73%
2 Technology 15.19%
3 Consumer Discretionary 11.89%
4 Industrials 10.67%
5 Energy 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPT icon
151
Sprout Social
SPT
$522M
$350K 0.12%
+6,030
New +$350K
VIR icon
152
Vir Biotechnology
VIR
$1.49B
$349K 0.12%
13,692
-1,850
-12% -$43.2K
ALTR
153
DELISTED
Altair Engineering Inc
ALTR
$331K 0.12%
6,311
CWAN
154
DELISTED
Clearwater Analytics
CWAN
$329K 0.12%
27,324
ZNTL icon
155
Zentalis Pharmaceuticals
ZNTL
$329M
$328K 0.11%
11,686
+3,510
+43% +$93K
ASND icon
156
Ascendis Pharma A/S
ASND
$16.7B
$308K 0.11%
3,315
JAMF
157
DELISTED
Jamf
JAMF
$304K 0.11%
12,293
+6,456
+111% +$181K
RPC
158
Ridgepost Capital
RPC
$971M
$296K 0.1%
26,608
RARE icon
159
Ultragenyx Pharmaceutical
RARE
$2.56B
$292K 0.1%
4,890
-640
-12% -$39.4K
RLAY icon
160
Relay Therapeutics
RLAY
$3.99B
$264K 0.09%
15,749
+200
+1% +$4.29K
SG icon
161
Sweetgreen
SG
$756M
$256K 0.09%
21,953
FSR
162
DELISTED
Fisker Inc.
FSR
$248K 0.09%
28,910
-7,280
-20% -$75.4K
RXRX icon
163
Recursion Pharmaceuticals
RXRX
$1.62B
$240K 0.08%
29,472
+800
+3% +$5.35K
ENFN
164
DELISTED
Enfusion, Inc.
ENFN
$232K 0.08%
22,759
WIX icon
165
WIX.com
WIX
$2.45B
$215K 0.08%
3,285
CHRS icon
166
Coherus Oncology
CHRS
$222M
$210K 0.07%
28,961
-230
-0.8% -$2K
VITL icon
167
Vital Farms
VITL
$592M
$190K 0.07%
21,697
DKNG icon
168
DraftKings
DKNG
$12.2B
$182K 0.06%
15,567
PACK icon
169
Ranpak Holdings
PACK
$550M
$165K 0.06%
23,637
-9,930
-30% -$128K
ADCT icon
170
ADC Therapeutics
ADCT
$141M
$123K 0.04%
15,515
ERAS icon
171
Erasca
ERAS
$6.3B
$119K 0.04%
21,367
+4,290
+25% +$28.1K
SHCO
172
DELISTED
Soho House & Co
SHCO
$95K 0.03%
14,684
XWEL icon
173
XWELL
XWEL
$8.87M
$22K 0.01%
1,568
ACVA icon
174
ACV Auctions
ACVA
$1.43B
-31,412
Closed -$465K
AMBA icon
175
Ambarella
AMBA
$3.03B
-6,500
Closed -$682K

Similar funds

CNA Financial's Q2 2022 Portfolio in Review

As of Q2 2022, CNA Financial held 198 positions worth $286M, down 11% from $322M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

CNA Financial deployed $14.1M of net new capital in Q2 2022, opening 11 new positions and adding to 56 existing holdings. Its largest new stake was HCA Healthcare: 62,500 shares worth $10.5M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Cigna, an estimated $644K trimmed.

  • CNA Financial's largest Q2 2022 buy was HCA Healthcare: 62,500 shares worth $10.5M.
  • CNA Financial added most to Meta Platforms (Facebook) in Q2 2022, an estimated $8.68M increase.
  • CNA Financial's biggest Q2 2022 reduction was Cigna, cutting an estimated $644K.
  • CNA Financial fully exited Fiserv Inc in Q2 2022, selling an estimated $7.1M.
  • CNA Financial's ten largest holdings make up 40% of its $286M portfolio in Q2 2022.
  • CNA Financial opened 11 new positions and closed 25 in Q2 2022.
  • CNA Financial's portfolio value fell 11% quarter-over-quarter to $286M.

Based on CNA Financial's 13F filing for Q2 2022, filed 9 Aug 2022.